S100A9 and systemic lupus erythematosus: Efficacy of S100A9 blocking by paquinimod was already shown in several mouse models of inflammatory diseases including experimental autoimmune encephalitis 54, liver fibrosis 55, lupus-prone MRL-lpr/lpr mouse model 56, and skin fibrosis 57.